644 results on '"Rihal CS"'
Search Results
2. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement
3. P650Influence of fetunin-a level on progression of calcific aortic valve stenosis The COFRASA - GENERAC StudyP651Common carotid artery remodeling 1 year after aortic valve surgeryP652Low gradient aortic stenosis with preserved ejection fraction: reclassification of severity by 3D transesophageal echocardiography. P653Results of balloon aortic valvuloplasty in patients with impaired left ventricle ejection fraction.P654Burden of associated aortic regurgitation in patients with mitral regurgitationP655Differences in right ventricular mechanics in acute and chronic ischemic mitral regurgitation after inferoposterior myocardial infarctionP656Tricuspid regurgitation in patients operated for severe symptomatic native aortic stenosis: pre-operative determinantsP657Echocardiographic diagnosis in patients with prosthetic or annuloplasty ring dysfunction: correlation with surgical findingsP659Agreement analisys of different three-dimensional transoesophageal echocardiographic modalities and cardiac CT scan in aortic annulus sizing for transapical heart valve implantationP660Elevated gradients after TAVR are associated with increased rehospitalization, but have no impact on mortality and major adverse cardiac eventsP661Echocardiographic characteristics of post-TAVI thrombosis and endocarditis: single-centre experienceP662Impact of mixed aortic valve disease in long-term mortality after transcatheter aortic valve implantationP663Quantification of mitral regurgitation during interventional valve repair: correlation between haemodynamic parameters and 3D color Doppler echocardiographyP664Mitraclip in functional mitral regurgitation: are immediate results the same in ischemic and non ischemic etiology?P665Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a meta-analysisP666Regardless of the definition used, left ventricular reverse remodeling is not different in fibrosis positive and negative dilated cardiomyopathy patientsP667Heterogeneity of LV contractile function by multidimensional strain in patients with EF<35%: Insights for the hemodynamic burdenP668Ability of 99mTc-DPD scintigraphy to predict conduction disorders requiring permanent pacemaker in patients with transthyretin-related cardiac amyloidosisP669Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: relation to electromechanical delayP670Could echocardiographic features differentiate Fabry cardiomyopathy from sarcomeric forms of hypertrophic cardiomyopathy?P671Pregnancy is well tolerated in women with arrhythmogenic right ventricular cardiomyopathy P672Glycogen storage cardiomyopathy (PRKAG2): do particular echocardiography findings in established and advanced techniques are helpful in suggesting the diagnosis?P673Improvement of arterial stiffness and myocardial deformation in patients with poorly controlled diabetes mellitus type 2 after optimization of antidiabetic medication
4. PCV68 IMPACT OF DRUG ELUTING STENTS ON CLINICAL AND ECONOMIC OUTCOMES IN AN UNSELECTED INTERVENTIONAL PRACTICE
5. Early, elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction is safe and effective
6. PCV86 THE ECONOMIC BURDEN OF EXPERIENCING MAJOR COMPLICATIONS DURING PERCUTANEOUS CORONARY INTERVENTION
7. Impact of Prehospital Electrocardiogram Protocol and Immediate Catheterization Team Activation for Patients With ST-Elevation-Myocardial Infarction.
8. Temporal Trends (over 30 Years), Clinical Characteristics, Outcomes, and Gender in Patients <=50 Years of Age Having Percutaneous Coronary Intervention.
9. Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery.
10. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
11. Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota.
12. Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study.
13. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
14. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
15. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
16. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience.
17. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents.
18. Coronary revascularization in the community a population-based study, 1990 to 2004.
19. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.
20. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience.
21. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores.
22. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
23. Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications.
24. Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population-based angiographic analysis.
25. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.
26. The changing face of coronary interventional practice. The Mayo Clinic experience.
27. Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction.
28. Levoatriocardinal vein with partial anomalous venous return and a bidirectional shunt.
29. Current status of endomyocardial biopsy.
30. Chronic coronary artery disease: diagnosis and management.
31. Frequency and predictors of urgent coronary angiography in patients with acute pericarditis.
32. Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis: Results From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)
33. Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention.
34. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation.
35. Diagnosis and treatment of viral myocarditis.
36. Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
37. Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction.
38. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.
39. Association of body mass index with outcome after percutaneous coronary intervention.
40. Percutaneous device closure of a large aortic root graft pseudoaneurysm using 3-dimensional transesophageal echocardiographic guidance.
41. Temporal Trends in Takotsubo Syndrome: Results From the International Takotsubo Registry.
42. Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock.
43. Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients.
44. Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States.
45. Transcatheter Versus Surgical Mitral Valve Interventions in Patients With Prior Coronary Artery Bypass Grafting.
46. Cardiac biomarkers for diagnosing Takotsubo syndrome.
47. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y 12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
48. Thirty-Day High-Grade Aortic Valve Block Post-Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor.
49. Pulmonary Vein Flow Morphology After Transcatheter Mitral Valve Edge-to-Edge Repair as Predictor of Survival.
50. Contemporary 1-Year Outcomes of Mitral Valve-in-Ring With Balloon-Expandable Aortic Transcatheter Valves in the U.S.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.